KNSA
Kiniksa Pharmaceuticals International
$63.54
+$0.70 (+1.11%)Jul 27, 2026
Key metrics
The numbers that frame KNSA today
- Market cap
- $4.89B
- P/E (TTM)
- 66.9
- EV / FCF
- 28.7
- Gross margin
- 89.3%
- EV / Sales
- 6.2
- ROIC
- 25.2%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $26.27
- 52wk High
- $67.53
Growth
Revenue and earnings trend for KNSA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KNSA
Is Kiniksa Pharmaceuticals International a good buy?
Yes. Kiniksa Pharmaceuticals International has strong quality and excellent momentum. Both signals support the setup. Growth looks mixed. The support signal is useful, but not decisive. We think Kiniksa Pharmaceuticals International is selling at a fair price.
What is the market capitalization of KNSA?
Kiniksa Pharmaceuticals International's market capitalization is $4.89B.
What is the P/E ratio for KNSA stock?
Kiniksa Pharmaceuticals International's current P/E ratio is 66.9.
What is the 52-week high for KNSA stock?
The 52-week high for Kiniksa Pharmaceuticals International is $67.53. The current close of $63.54 is 5.9% below that high.
What is the 52-week low for KNSA stock?
The 52-week low for Kiniksa Pharmaceuticals International is $26.27. The current close of $63.54 is 141.9% above that low.
Does KNSA stock pay dividends?
Kiniksa Pharmaceuticals International does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KNSA?
Kiniksa Pharmaceuticals International's Debt / Equity ratio is 0.02.